Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma
Authors:
- 1 March 2010
- journal article
- Published by Wiley in Dermatologic Therapy
- Vol. 23 (s2) , S33-S36
Abstract
Matrix metalloproteinases (MMPs) are associated with Kaposi's sarcoma (KS) tumorigenesis and may contribute to the mechanism of KS invasive growth. To date, only a few MMPs have been studied in KS lesions, and exactly which MMPs are involved in KS development and progression remains unanswered. However, MMPs 2 and 9 have been associated with different phases of angiogenesis, but their role in the proteolytic modification of the extracellular matrix has not been investigated. The results of this study confirm that MMPs, specifically MMP-2 and MMP-9, can contribute to angiogenesis by disrupting the vessel basement membrane and other extracellular matrix barriers, and enabling endothelial cells migration through the surrounding tissues.Keywords
This publication has 8 references indexed in Scilit:
- Evidence of COX-1 and COX-2 expression in Kaposi’s sarcoma tissuesEuropean Journal of Cancer, 2007
- Matrix metalloproteinases in the progression and regression of Kaposi’s sarcomaJournal of Cutaneous Pathology, 2006
- COL-3 benefits patients with AIDS-related Kaposi's sarcomaThe Lancet Oncology, 2006
- HIV protease inhibitors as new treatment options for Kaposi’s sarcomaDrug Resistance Updates, 2003
- HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcomaNature Medicine, 2002
- Activation of Matrix-Metalloproteinase-2 and Membrane-Type-1-Matrix-Metalloproteinase in Endothelial Cells and Induction of Vascular Permeability In Vivo by Human Immunodeficiency Virus-1 Tat Protein and Basic Fibroblast Growth FactorMolecular Biology of the Cell, 2001
- Biology of Kaposi's sarcomaEuropean Journal of Cancer, 2001
- Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitroJournal of Cellular Physiology, 1993